Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bone-breaking cancer treatment.

× No keyword cloud information.

10 in total

1. Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitors.

Authors: Jinlu Dai; Yi Lu; Chunyan Yu; Jill M Keller; Atsushi Mizokami; Jian Zhang; Evan T Keller
Journal: Cancer Res Date: 2010-05-25 Impact factor: 12.701

2. MAPK11 in breast cancer cells enhances osteoclastogenesis and bone resorption.

Authors: Zhimin He; Jin He; Zhiqiang Liu; Jingda Xu; Sofia F Yi; Huan Liu; Jing Yang
Journal: Biochimie Date: 2014-07-24 Impact factor: 4.079

3. p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction.

Authors: Jin He; Zhiqiang Liu; Yuhuan Zheng; Jianfei Qian; Haiyan Li; Yong Lu; Jingda Xu; Bangxing Hong; Mingjun Zhang; Pei Lin; Zhen Cai; Robert Z Orlowski; Larry W Kwak; Qing Yi; Jing Yang
Journal: Cancer Res Date: 2012-10-11 Impact factor: 12.701

Review 4. The best of both worlds - managing the cancer, saving the bone.

Authors: Issam Makhoul; Corey O Montgomery; Dana Gaddy; Larry J Suva
Journal: Nat Rev Endocrinol Date: 2015-10-27 Impact factor: 43.330

5. Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292.

Authors: Koh Furugaki; Yoichiro Moriya; Toshiki Iwai; Keigo Yorozu; Mieko Yanagisawa; Kumiko Kondoh; Kaori Fujimoto-Ohuchi; Kazushige Mori
Journal: Clin Exp Metastasis Date: 2011-06-18 Impact factor: 5.150

6. Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma.

Authors: J Yang; J He; J Wang; Y Cao; J Ling; J Qian; Y Lu; H Li; Y Zheng; Y Lan; S Hong; J Matthews; M W Starbuck; N M Navone; R Z Orlowski; P Lin; L W Kwak; Q Yi
Journal: Leukemia Date: 2012-03-19 Impact factor: 11.528

7. The Inhibitory Effects of Forsythia Koreana Extracts on the Metastatic Ability of Breast Cancer Cells and Bone Resorption by Osteoclasts.

Authors: Yu Li Kim; Sun Kyoung Lee; Kwang-Kyun Park; Won-Yoon Chung
Journal: J Cancer Prev Date: 2016-06-30

8. The effect of laminin-1-doped nanoroughened implant surfaces: gene expression and morphological evaluation.

Authors: Humberto Osvaldo Schwartz-Filho; Kostas Bougas; Paulo G Coelho; Ying Xue; Mariko Hayashi; Rafael Silveira Faeda; Rosemary Adriana Chiérici Marcantonio; Daisuke Ono; Fumio Kobayashi; Kamal Mustafa; Ann Wennerberg; Ryo Jimbo
Journal: Int J Biomater Date: 2012-12-12

9. Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells.

Authors: Sun Kyoung Lee; Kwang-Kyun Park; Ki Rim Kim; Hyun-Jeong Kim; Won-Yoon Chung
Journal: J Cancer Prev Date: 2015-12-30

10. Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis.

Authors: Sun Kyoung Lee; Kwang-Kyun Park; Hyun-Jeong Kim; Junhee Park; Seung Hwa Son; Ki Rim Kim; Won-Yoon Chung
Journal: Sci Rep Date: 2017-08-29 Impact factor: 4.379

10 in total